摘要
本研究应用我室建立的稳定表达CytP4501A1的转基因细胞株CHL-1A1对一组前致突变物/前致癌物进行双核细胞微核试验,同时以母细胞系CHL为对照,结果表明,在不加S9的情况下,五种前致突变物,苯并(α)芘、3-甲基胆蒽、苯并蒽、二甲基苯蒽和蒽均能诱导CHL-1A1细胞的微核率显著增高,并具有剂量反应关系,证明CHL-1A1细胞具备代谢活化多环芳烃类化合物的能力。因此,转基因细胞株CHL-1A1在化学致癌物的遗传毒理学研究方面具有重要的应用价值。
The bioactivation of a panel of promutagens[Benzo(a) pyrene(B(a)P),3-Methylcholanthrene(3-MC),1,2-Benzanthrance(BA),7, 12-Dimethylbenz(a)an-thracene(DMBA),Anthracene(A)] in CHL cell line and that transfected with recombinanthuman Cyt P450 1A1 cDNA expression plasmid(CHL-1Al cell line)were studied.The endpoint selected was the induction of micronuclei assay. All chemicals tested induced repro-ducible micronuclei,and the dose-response relations were observed. This study demon-strates the benefit of using transgenic cell line CHL-1A1 in short term mutagenicity assayin vitro for polycyclic aromatic hydrocarbons and also the potential use in metabolic pathwaystudy.
出处
《癌变.畸变.突变》
CAS
CSCD
1996年第3期136-140,共5页
Carcinogenesis,Teratogenesis & Mutagenesis
基金
国家和浙江省自然科学基金